BofA downgraded CSN to Underperform from Neutral with a price target of $2.90, down from $3.90. The firm sees weaker operational cash generation from lower iron ore prices and the company’s “still high capex bill,” the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
